- Home
- Publications
- Publication Search
- Publication Details
Title
siRNA-Conjugated Nanoparticles to Treat Ovarian Cancer
Authors
Keywords
-
Journal
SLAS Technology
Volume -, Issue -, Pages 247263031881666
Publisher
SAGE Publications
Online
2019-01-09
DOI
10.1177/2472630318816668
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo
- (2018) Chang Yu et al. BIOMATERIALS
- Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70 S6K with Dendrimer Nanovector-Based siRNA Delivery
- (2018) Jing Ma et al. MOLECULAR THERAPY
- Mechanisms of clathrin-mediated endocytosis
- (2018) Marko Kaksonen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Patisiran: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- ABCF2 , an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells
- (2017) Lingjie Bao et al. MOLECULAR CARCINOGENESIS
- Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models
- (2017) Cai M. Roberts et al. Nanomedicine-Nanotechnology Biology and Medicine
- Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer
- (2017) Rajesh Kotcherlakota et al. Journal of Materials Chemistry B
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanoparticle-siRNA: A potential cancer therapy?
- (2016) Samuel Wang Sherng Young et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy
- (2016) Bo Xiao et al. Expert Opinion on Drug Delivery
- Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle
- (2016) Yao Chen et al. NANOTECHNOLOGY
- Highly efficient Gab2 siRNA delivery to ovarian cancer cells mediated by chitosan–polyethyleneimine nanoparticles
- (2016) Lei Wang et al. Journal of Materials Chemistry B
- Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity
- (2016) Minati Satpathy et al. Scientific Reports
- Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer
- (2015) Chunbai He et al. BIOMATERIALS
- Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer
- (2015) G. Salzano et al. MOLECULAR CANCER THERAPEUTICS
- Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden
- (2015) James Finlay et al. Nanomedicine-Nanotechnology Biology and Medicine
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis
- (2015) James Finlay et al. Biomed Research International
- Twist Modulates Breast Cancer Stem Cells by Transcriptional Regulation of CD24 Expression
- (2015) Farhad Vesuna et al. NEOPLASIA
- Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles
- (2015) Mian M.K. Shahzad et al. NEOPLASIA
- Recent Advances in Nanoparticle-Mediated siRNA Delivery
- (2014) John-Michael Williford et al. Annual Review of Biomedical Engineering
- An inhibition of p62/SQSTM1 caused autophagic cell death of several human carcinoma cells
- (2014) Kaito Nihira et al. CANCER SCIENCE
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system
- (2014) MEIHUI XIA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer
- (2014) Xiaoqian Yang et al. PHARMACEUTICAL RESEARCH
- RNA interference: concept to reality in crop improvement
- (2014) Satyajit Saurabh et al. PLANTA
- Co-Delivery of Doxorubicin and siRNA with Reduction and pH Dually Sensitive Nanocarrier for Synergistic Cancer Therapy
- (2014) Weicai Chen et al. Small
- The heterogeneity of ovarian cancer
- (2013) I. Meinhold-Heerlein et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies
- (2013) Diana P. English et al. Molecular Diagnosis & Therapy
- Single-Step Nanoplasmonic VEGF165 Aptasensor for Early Cancer Diagnosis
- (2012) Hansang Cho et al. ACS Nano
- Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly
- (2012) Qinglian Hu et al. BIOMATERIALS
- Exploiting p70 S6 kinase as a target for ovarian cancer
- (2012) Carman KM Ip et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Effects and mechanism of downregulation of survivin expression by RNA interference on proliferation and apoptosis of lung cancer cells
- (2012) XIANG-QI CHEN et al. Molecular Medicine Reports
- Doxorubicin Induces Cytotoxicity through Upregulation of pERK–Dependent ATF3
- (2012) Eun-Jung Park et al. PLoS One
- Modeling RNA interference in mammalian cells
- (2011) Giulia Cuccato et al. BMC Systems Biology
- p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins
- (2011) Huimei Yu et al. EUROPEAN JOURNAL OF CANCER
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
- (2011) H. W. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
- (2010) Ranit Kedmi et al. BIOMATERIALS
- Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer
- (2010) C. M. Annunziata et al. CLINICAL CANCER RESEARCH
- The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
- (2010) Raga Krishnakumar et al. MOLECULAR CELL
- Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells
- (2010) M. S. Goldberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
- (2010) K. N. Sugahara et al. SCIENCE
- siRNA delivery systems for cancer treatment
- (2009) Yu-Kyoung Oh et al. ADVANCED DRUG DELIVERY REVIEWS
- Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group
- (2009) David S. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional gene silencing mediated by chitosan/siRNA nanocomplexes
- (2009) A M Ji et al. NANOTECHNOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- p70 S6 Kinase Promotes Epithelial to Mesenchymal Transition through Snail Induction in Ovarian Cancer Cells
- (2008) Y. L. Pon et al. CANCER RESEARCH
- A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
- (2008) Alan Ashworth JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now